Photo from wikipedia
To examine the dynamics of treatment with 2 bone‐targeting agents (BTAs)—denosumab and zoledronic acid—among men with bone metastases from prostate cancer. Click to show full abstract
To examine the dynamics of treatment with 2 bone‐targeting agents (BTAs)—denosumab and zoledronic acid—among men with bone metastases from prostate cancer.
Keywords:
bone targeting;
bone metastases;
metastases prostate;
targeting agents;
among men;
men bone
Journal Title: Pharmacoepidemiology and Drug Safety
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Pharmacoepidemiology and Drug Safety
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!